Page 190 - Mployee Wellness Programs News Today

Even with innovative and dependable technology, remember that people are your organization’s most important asset. Trust them, protect them, and let them shine. Healthcare will be better for it.

The pandemic taught hospitals that neglecting supply chain data has a cost in the form of stock outs and increased costs, but while these concerns are fading, supply chain challenges are not. As a result, hospitals that do not act now risk jeopardizing their own financial future.

Health Net's “Review to Renew” campaign will leverage print and digital media — such as mail, interactive voice response calls, text messages, social media, digital advertisements and posters — to make Medi-Cal members aware of the end of the continuous enrollment requirement and provide them with resources to retain coverage.

GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users' data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.

Protectionism against (and fear of) telehealth on display from companies like Walmart and states like Alabama threaten the only effective and scalable solution to America’s opioid epidemic.

Under the proposed new rule, employers are no longer able to be exempt from covering contraception due to moral convictions, but religious exemptions still remain. It's an important move from the government during the reproductive health crisis, one advocate said.

The FDA approved GSK drug Jesduvroq for treating anemia in patients with chronic kidney disease. The once-daily pill is the first oral medicine to pass FDA muster in this indication, giving patients a more convenient alternative to injectable anemia therapies.

Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi's protégé writes why her research is so important.

Two Congresspeople recently introduced a bill seeking to terminate the VA's Oracle Cerner EHR rollout. The legislation said that the project is too flawed and costly to carry on — the lawmakers called for VA facilities to revert back to the department’s internally developed EHR.

Karuna Therapeutics has licensed two small molecules that shuttering Goldfinch Bio had developed for kidney disorders. These compounds target a pathway that could also treat neurological disorders, giving clinical-stage Karuna the opportunity to compete against a drug candidate from Boehringer Ingelheim.